Retreatment With Radium-223 Found Safe in mCRPC
Wednesday, 1st June 2016
Luke Nordquist, MD, discusses a study investigating a higher dose of radium-223 dichloride (Xofigo) in patients with metastatic castration-resistant prostate cancer and the ongoing potential of the agent in treating the disease.
This article was picked up by Colin Hubball - thanks Colin !
PSA Testing at Congleton Golf Club - Open to Non-Members
30 May 2019 19:00–22:00
PSA Testing at Ashton-under-Lyne Golf Club
15 Jun 2019 10:00–13:00
PSA Testing at Warrington Golf Club (Closed Event)
29 Jun 2019 11:00–14:00
Group Meeting at Leighton Hospital, Crewe
13 Jul 2019 10:00–12:00
PSA Testing at Sandiway Golf Club
13 Jul 2019 11:00–14:00